TP53 and Thrombocytopenia: One of these molecules is Nutlin-3A, which inhibits the interaction between the 2 genes and stabilizes p53, the disadvantage being the very low clinical efficacy and the limitation of the therapeutic dose secondary to severe thrombocytopenia.[13]